A prospective study of patient-reported xerostomia-related outcomes after parotidectomy

被引:6
作者
Brodie, Kara D. [1 ]
Zebolsky, Aaron L. [1 ]
Ochoa, Edgar [2 ]
Ha, Patrick K. [3 ]
Heaton, Chase M. [3 ]
El-Sayed, Ivan H. [3 ]
Ryan, William R. [3 ]
机构
[1] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Sch Med, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Div Head & Neck Oncol & Endocrine Surg, Dept Otolaryngol Head & Neck Surg, Helen Diller Comprehens Canc Ctr,UCSF Mission Bay, 1825 4th St,5th Floor, San Francisco, CA 94158 USA
关键词
parotidectomy; patient reported outcome measures; xerostomia; QUALITY-OF-LIFE; NECK-CANCER; HEAD; RADIOTHERAPY; SALIVA; VERSION;
D O I
10.1002/lio2.568
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective There is a paucity of data on patient-reported outcome measures regarding xerostomia after parotidectomy surgery. Although salivary flow rates after parotidectomy have been previously studied, they do not correlate with subjective xerostomia. This study was designed to evaluate if unilateral parotidectomy increases patient-reported xerostomia. Methods A prospective cohort of patients undergoing unilateral partial, superficial, or total parotidectomy for benign or low-grade malignant pathology without postoperative radiation at a tertiary care academic center was studied. We analyzed patient-reported outcome measures of xerostomia using the Xerostomia Questionnaire (XQ) preoperatively and postoperatively. We compared pre- and postoperative cumulative and individual XQ scores using Wilcoxon signed-rank tests. We stratified patients by the weight in grams (g) of the parotid tissue excised, pathology, smoking status, and xerostomia-related medication use. Results Twenty-two adults with benign or low grade malignant unilateral parotid tumors were included. Postoperative questionnaires were completed at a median of 10.2 months (interquartile range [IQR] 8.6-11.9) after unilateral parotidectomy. Mean preoperative and postoperative cumulative XQ scores, on a 100-point scale, with higher scores representing worse symptoms, were 10.33 (95% CI: 4.46-16.20) and 10.54 (95% CI: 5.10-15.98), respectively, with a mean change of +0.21 (p = 0.472). There were no statistically significant changes in individual XQ symptom scores. Neither type of parotidectomy, resection specimens weighing over 10 g, smoking habits, xerostomia-related medication use, nor malignant pathology were associated with worse symptom scores. Conclusion Based on these data, unilateral parotidectomy does not appear to definitely, or at least consistently, increase xerostomia per patient reporting. More extensive parotid resections are not associated with worse symptom scores. These data can help guide preoperative counseling and postoperative expectations for parotidectomy. Level of Evidence 2b.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 21 条
[1]   Surgery of the major salivary glands and its impact on salivary flow-A review [J].
Burghartz, Marc ;
Hackenberg, Stephan ;
Sittel, Christian ;
Hagen, Rudolf .
LARYNGOSCOPE, 2019, 129 (09) :2053-2058
[2]   Post Parotidectomy Quality of Life in Patients with Benign Parotid Neoplasm: A Prospective Study [J].
Chaudhary, Vipul Kumar ;
Rawat, Digvijay Singh ;
Tailor, Manish ;
Verma, Praveen Chandra ;
Aseri, Yogesh ;
Singh, B. K. .
INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2019, 71 (Suppl 1) :363-368
[3]   Salivary flow dynamics after parotid surgery: A preliminary report [J].
Chaushu, G ;
Dori, S ;
Sela, BA ;
Taicher, S ;
Kronenberg, J ;
Talmi, YP .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 124 (03) :270-273
[4]   Outcome, general, and symptom-specific quality of life after various types of parotid resection [J].
Ciuman, Raphael Richard ;
Oels, Wolfgang ;
Jaussi, Rolf ;
Dost, Philipp .
LARYNGOSCOPE, 2012, 122 (06) :1254-1261
[5]   Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer [J].
Eisbruch, A ;
Kim, HM ;
Terrell, JE ;
Marsh, LH ;
Dawson, LA ;
Ship, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (03) :695-704
[6]   How should we measure and report radiotherapy-induced xerostomia? [J].
Eisbruch, A ;
Rhodus, N ;
Rosenthal, D ;
Murphy, B ;
Rasch, C ;
Sonis, S ;
Scarantino, C ;
Brizel, D .
SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (03) :226-234
[7]  
FOX PC, 1987, JADA, V110, P519
[8]   Xerostomia - Etiology, recognition and treatment [J].
Guggenheimer, J ;
Moore, PA .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2003, 134 (01) :61-69
[9]   Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report [J].
Jabbari, S ;
Kim, HM ;
Feng, M ;
Lin, A ;
Tsien, C ;
Elshaikh, M ;
Terrel, JE ;
Murdoch-Kinch, C ;
Eisbruch, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03) :725-731
[10]   Effects of benign parotid tumors on unstimulated saliva secretion from the parotid gland [J].
Jezewska, Elzbieta ;
Scinska, Anna ;
Kukwa, Wojciech ;
Bienkowski, Przemyslaw .
AURIS NASUS LARYNX, 2009, 36 (05) :586-589